These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28942094)

  • 1. Effects of n-3 fatty acid treatment on monocyte phenotypes in humans with hypertriglyceridemia.
    Dai Perrard XY; Lian Z; Bobotas G; Dicklin MR; Maki KC; Wu H
    J Clin Lipidol; 2017; 11(6):1361-1371. PubMed ID: 28942094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of MAT9001 containing eicosapentaenoic acid and docosapentaenoic acid, compared to eicosapentaenoic acid ethyl esters, on triglycerides, lipoprotein cholesterol, and related variables.
    Maki KC; Bobotas G; Dicklin MR; Huebner M; Keane WF
    J Clin Lipidol; 2017; 11(1):102-109. PubMed ID: 28391875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Head-to-Head Comparison of a Free Fatty Acid Formulation of Omega-3 Pentaenoic Acids Versus Icosapent Ethyl in Adults With Hypertriglyceridemia: The ENHANCE-IT Study.
    Maki KC; Bays HE; Ballantyne CM; Underberg JA; Kastelein JJP; Johnson JB; Ferguson JJ
    J Am Heart Assoc; 2022 Mar; 11(6):e024176. PubMed ID: 35232215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
    Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD11c/CD18 expression is upregulated on blood monocytes during hypertriglyceridemia and enhances adhesion to vascular cell adhesion molecule-1.
    Gower RM; Wu H; Foster GA; Devaraj S; Jialal I; Ballantyne CM; Knowlton AA; Simon SI
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):160-6. PubMed ID: 21030716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia.
    Backes J; Anzalone D; Hilleman D; Catini J
    Lipids Health Dis; 2016 Jul; 15(1):118. PubMed ID: 27444154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
    Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
    Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
    Maki KC; Orloff DG; Nicholls SJ; Dunbar RL; Roth EM; Curcio D; Johnson J; Kling D; Davidson MH
    Clin Ther; 2013 Sep; 35(9):1400-11.e1-3. PubMed ID: 23998969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of TAK-085 compared with eicosapentaenoic acid in Japanese subjects with hypertriglyceridemia undergoing lifestyle modification: the omega-3 fatty acids randomized double-blind (ORD) study.
    Tatsuno I; Saito Y; Kudou K; Ootake J
    J Clin Lipidol; 2013; 7(3):199-207. PubMed ID: 23725919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK;
    Circulation; 2019 Sep; 140(12):e673-e691. PubMed ID: 31422671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postprandial Monocyte Activation in Individuals With Metabolic Syndrome.
    Khan IM; Pokharel Y; Dadu RT; Lewis DE; Hoogeveen RC; Wu H; Ballantyne CM
    J Clin Endocrinol Metab; 2016 Nov; 101(11):4195-4204. PubMed ID: 27575945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.
    Hedengran A; Szecsi PB; Dyerberg J; Harris WS; Stender S
    Lipids; 2015 Feb; 50(2):165-75. PubMed ID: 25403919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red Blood Cell Docosapentaenoic Acid (DPA n-3) is Inversely Associated with Triglycerides and C-reactive Protein (CRP) in Healthy Adults and Dose-Dependently Increases Following n-3 Fatty Acid Supplementation.
    Skulas-Ray AC; Flock MR; Richter CK; Harris WS; West SG; Kris-Etherton PM
    Nutrients; 2015 Aug; 7(8):6390-404. PubMed ID: 26247967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study.
    Ide K; Koshizaka M; Tokuyama H; Tokuyama T; Ishikawa T; Maezawa Y; Takemoto M; Yokote K
    Lipids Health Dis; 2018 Mar; 17(1):51. PubMed ID: 29544483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).
    Braeckman RA; Manku MS; Bays HE; Stirtan WG; Soni PN
    Prostaglandins Leukot Essent Fatty Acids; 2013 Sep; 89(4):195-201. PubMed ID: 23992935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study.
    Budoff M; Brent Muhlestein J; Le VT; May HT; Roy S; Nelson JR
    Clin Cardiol; 2018 Jan; 41(1):13-19. PubMed ID: 29365351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
    Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.